Details of the Drug

General Information of Drug (ID: DMSP9Q1)

• Drug Name: HIV vaccine
• Synonyms: HIVA vaccine, Oxford University/Nairobi University; HIV vaccine (prophylactic, DNA/MVA prime-boost); HIV vaccine (prophylactic, Prime-Boost), Oxford University; HIV-1 clade A gag p24/p17 vaccine, Oxford University/Nairobi University; HIVA DNA/MVA vaccine (AIDS), Oxford University/Nairobi University; HIVA DNA/MVA vaccine (HIV), Oxford University/Nairobi University; MVA HIV vaccine (prophylactic, Prime-Boost), Oxford University; Modified vaccinia Ankara (MVA) HIV vaccine (prophylactic, Prime-Boost), Oxford University; HIV subtype A vaccine (prophylactic, DNA/MVA prime-boost), Oxford University/Nairobi University; HIV vaccine (prophylactic, DNA/MVA prime-boost), Oxford University/Nairobi University; HIV-1 vaccine (prophylactic, DNA/MVA prime-boost), Oxford University/Nairobi University

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Phase 1	[1]

• Cross-matching ID: TTD ID: D0K2GV

References

• [1] Clinical pipeline report, company report or official report of GeoVax.